Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Expand
titleStudy 123, Report Table

The following shows the tabulated data as it is represented in a report for this study.  This report includes summary statistics (e.g. Average, Standard Deviation, Coeff. Var.); however, statistics are not included in the SEND standard and will not be represented in the SEND domains example. 

Neutral Red Cytotoxicity Assay Results (Relative Absorbance Data)

Run-Port Number

Sample ID

Smoke Fraction

Replicate Number

Plate Number

Well Number

Relative Assay Plate Absorbance Readings

Cigarette Smoke Condensate (µg/mL)

SLS (µg/mL)

10

50

75

100

120

140

160

200

110

200

1-1

030001

A

1

1

1

100

83.0

56.7

29.5

13.0

8.57

4.44

1.76

13.7

0.547

1-1

030001

A

1

1

2

107

77.7

65.7

30.2

15.6

9.79

5.41

2.49

8.09

0.791

1-1

030001

A

1

1

3

98.6

77.4

57.7

35.8

8.09

7.36

3.22

0.791

6.38

0.061

1-1

030001

A

1

1

4

94.9

81.5

38.2

31.2

7.60

5.17

3.22

0.791

5.17

0.304

1-1

030001

A

1

1

5

111

78.1

64.5

32.9

8.82

5.90

2.74

1.28

10.3

0.547

1-1

030001

A

1

1

6

96.6

76.2

48.0

26.8

7.84

4.20

2.74

1.52

8.09

4.93

1-1

030001

A

1

1

7

105

77.9

58.2

28.3

8.09

4.68

1.76

0.547

8.57

1.76

1-1

030001

A

1

1

8

95.2

74.0

47.2

24.4

8.57

3.71

3.47

0.304

11.2

0.791

Average

101

78.2

54.5

29.9

9.70

6.17

3.37

1.19

8.94

1.22

Std. Dev.

6

2.9

9.4

3.6

2.95

2.19

1.12

0.72

2.72

1.58

Coeff. Var.

5.8

3.6

17.2

11.9

30.4

35.5

33.1

61.0

30.5

129.9

1-1

030001

A

1

2

1

93.4

74.0

56.0

35.1

11.8

8.70

5.10

1.98

5.34

1.02

1-1

030001

A

1

2

2

102

75.2

53.3

35.1

11.8

7.74

5.58

3.66

5.34

1.02

1-1

030001

A

1

2

3

107

79.0

55.0

26.5

10.1

6.06

3.66

1.74

7.02

0.780

1-1

030001

A

1

2

4

104

80.2

55.3

29.8

8.94

3.90

3.66

1.50

6.30

0.780

1-1

030001

A

1

2

5

101

75.7

54.1

26.7

4.86

4.38

1.26

1.02

6.30

1.02

1-1

030001

A

1

2

6

110

85.7

67.7

26.0

5.34

4.62

3.42

1.50

6.30

0.540

1-1

030001

A

1

2

7

104

77.8

64.9

27.7

8.22

3.18

2.46

1.02

6.30

0.780

1-1

030001

A

1

2

8

103

71.6

58.9

25.5

9.42

4.14

3.90

1.26

4.38

0.780

Average

103

77.4

58.1

29.0

8.82

5.34

3.63

1.71

5.91

0.840

Std. Dev.

5

4.4

5.3

4.0

2.63

1.97

1.37

0.86

0.83

0.170

Coeff. Var.

4.6

5.6

9.2

13.6

29.8

36.9

37.6

50.0

14.1

20.2

to.xpt

do.xpt

di.xpt

Expand
titlets.xpt (trial summary, study level parameters)
  • Assumption: The intent of this dataset is to provide a summary of trial (study) information. This is not subject-level data. 
  • Assumption: A Trial (study) can have more than one assay type
  • Assumption: ASSAYID value of ALL indicates that it applies to all assays in the study
  • Sponsor should be "applicant", how do we represent this?  In text explanation in the IG?  In definition in CT/Parmcd/Parm? ** Need to have CT discussion, include Erin M.**
  • TK6, human keratinocyte, is this the "test system"?
  • Can we draft a starting list of Study Types and Sub Types to submit to CT now?
  • Is there a dictionary of species and/or strain that we would use? (see example)

Row

STUDYID

ASSAYID

DOMAIN

TSSEQ

TSGRPID

TSPARMCD

TSPARM

TSVAL

TSVALNF

1123NRUTS1
GLPTYPGood Laboratory Practice TypeFDA
2123NRUTS2
GLPTYPGood Laboratory Practice TypeOECD
3123NRUTS1
STSTDTCStudy Start Date2022-05-25
4123NRUTS1
STITLEStudy Title

Determination of the in vitro genotoxicity potential using the in vitro Neutral Red Uptake assay


5123NRUTS1
SNDIGVERSEND Implementation Guide VersionTOBACCO IMPLEMENTATION GUIDE VERSION 1.0
6123NRUTS1
SNDCTVERSEND Controlled Terminology VersionSEND Terminology 2021-09-30
7123NRUTS1
SSPONSORSponsor Applicant's OrganizationExample Applicant Inc.
8123NRUTS1
SPREFIDSponsor's Applicant's Study Reference ID
NOT APPLICABLE
9123NRUTS11TSTFNAMTest Facility NameExample Tox Testing Lab Name
10123NRUTS11TSTFLOCTest Facility Location10 Somewhere Street, Montgomery, AL 10000
11123NRUTS11TFCNTRYTest Facility CountryUSA
12123NRUTS11STDIRStudy DirectorDr. R. Smith
13123NRUTS1
GLPFLGLP FlagY
14123NRUTS1
ASTDAssay StandardNIH Publication No. 07-4519
15123NRUTS1
ASTDVAssay Standard Version2006-11
16123NRUTS1
SSTYPStudy TypeGENOTOXICITY IN VITRO
17123NRUTS1
SSSTYPStudy Sub TypeIn Vitro Neutral Red Uptake
18123NRUTS1
SPECIESSpeciesSalmonella enterica 
19123NRUTS1
??Test System??TK6 Normal Human Keratinocyte
Definitions
Expand
titletx.xpt (trial sets)
  • Assumption: The Trial Sets (TX) domain provides the list of distinct sets of subjects having different experimental factors, treatment factors, inherent characteristics, or distinct sponsor applicant designations as specified in the trial design.
  • During CT definition/reviews will decide appropriate TXPARM and TXVAL; Treatment duration may be controlled;  For now, we just include good example values based on our experience
  • Where are the details of the smoke regime defined/submitted today? (e.g., puff profile = Bell shaped puffing volumes; Puff Block = 50%, etc.)
  • Smoke fraction?  is this indicator of processing of material from smoke machine..we used Smoke Exposure System - ok?
  • Incubate cells (37 ºC ±1 ºC, 90% ±10% humidity, and 5% ±1% CO2/air) - these are ranges, do we model for ranges?
RowSTUDYIDASSAYIDDOMAINSETCD
SET (what sponsor calls it)
TXSEQTXPARMCDTXPARMTXVAL
RowSTUDYIDASSAYIDDOMAINSETCD
SET (what sponsor calls it)
TXSEQTXPARMCDTXPARMTXVAL
1123NRUTX1-1-A
(plate-col-row in the 96-well plate)
CSC-10
(through SLS-200)
1
PLATENUM. (e.g., 1 or 2)
1
2123NRUTX1-1-ACSC-102
WELLNUM (e.g., 1-A through 10-H)
Number representing the location of the well in the 96-well plate1-A 
3123NRUTX1-1-ACSC-103INTRVNname of the intervention articleCigarette Smoke Condensate
4123NRUTX1-1-ACSC-104ITVTYPE
(CT e.g, Product, positive control, negative control, vehicle control, solvent control)
type of intervention articlePRODUCT 
5123NRUTX1-1-ACSC-105ITVCONCintervention concentration10
6123NRUTX1-1-ACSC-106ITVCONCUintervention unitug/ml
7123NRUTX1-1-ACSC-107STRAINStrain/SubstrainSalmonella enterica enterica
8123NRUTX1-1-ACSC-108
REGIMESmoking RegimeTraditional combustible 
SPDEVIDSponsor defined device identifierPUFFMASTER3k
9123NRUTX1-1-ACSC-109
RUN

Assay run number

DUREFIDSmoking RegimeMedium Intensity Regimen
1
10123NRUTX1-1-ACSC-1010
PORT
RUN

Assay run number

Port ID

1

11123NRUTX1-1-ACSC-1011SMPLIDSample ID030001
12123NRUTX1-1-ACSC-1012
SMKFRC
SMKEXSYSSmoke
Fraction
Exposure SystemCambridge filter pad, eluted in DMSO
A
13123NRUTX1-1-ACSC-1013REPNUMReplicate Number1
14123NRUTX1-1-ACSC-10
SPDEVIDSponsor defined device identifierPUFFMASTER3K
14TRTDMINTreatment Duration Min47.5
15123NRUTX1-1-ACSC-1015
DUREFIDSmoke RegimenMedium Intensity Regimen
TRTDTRGTreatment Duration Target48
16
1
123NRUTX1-1-
B
ACSC-10
PLATENUM. (e.g., 1 or 2)
1
16TRTDMAXTreatment Duration Max48.5
17
2
123NRUTX1-1-
B
ACSC-10
WELLNUM
17TRTDUTreatment Duration UnitHOURS
18123NRUTX1-
(e.g.,
1-A
through 10-H)Number representing the location of the well in the 96-well plate1-A 
CSC-1018INCBTMPIncubation Temperature37
19123NRUTX1-1-ACSC-1019INCBTMPUIncubation Temperature UnitC
20123NRUTX1-1-ACSC-1020MEDIAComposition of MediaSartorius HEK293
21123NRUTX1-1-ACSC-1021HUMIDAtmospheric Relative Humidity  Percent90
22123NRUTX1-1-ACSC-1022ATMCO2Atmospheric CO2 Percent5
23123NRUTX1-1-ACSC-1023SPTOBID

Sponsor defined tobacco identifier

CIG01a
1123NRUTX1-1-BCSC-101
PLATENUM. (e.g., 1 or 2)
1
2123NRUTX1-1-BCSC-102
WELLNUM (e.g., 1-A through 10-H)
Number representing the location of the well in the 96-well plate1-A 
3123NRUTX1-1-BCSC-103INTRVNname of the intervention articleCigarette Smoke Condensate
4123NRUTX1-1-BCSC-104ITVTYPE
(CT e.g, Product, positive control, negative control)
type of intervention articlePRODUCT
5123NRUTX1-1-BCSC-105ITVCONCintervention concentration10
6123NRUTX1-1-BCSC-106ITVCONCUintervention unitug/ml
7123NRUTX1-1-BCSC-107STRAINStrain/SubstrainSalmonella enterica enterica
8123NRUTX1-1-BCSC-108SPDEVIDSponsor defined device identifierPUFFMASTER3k
9123NRUTX1-1-BCSC-109DUREFIDSmoking RegimeMedium Intensity Regimen
10123NRUTX1-1-BCSC-1010RUN 

Assay run number

1

11
3
123NRUTX1-1-BCSC-1011
INTRVNname of the intervention articleCigarette Smoke Condensate
SMPLIDSample ID030001
12
4
123NRUTX1-1-BCSC-10
ITVTYPE
(CT e.g, Product, positive control, negative control)
type of intervention articlePRODUCT
12SMKEXSYSSmoke Exposure SystemCambridge filter pad, eluted in DMSO
13
5
123NRUTX1-1-BCSC-1013
ITVCONC
REPNUM 
intervention concentration
Replicate Number
10
1
6
14123NRUTX1-1-BCSC-1014
ITVCONCUintervention unitug/ml
TRTDMINTreatment Duration Min47.5
15
7
123NRUTX1-1-BCSC-1015
STRAINStrain/SubstrainSalmonella enterica enterica
TRTDTRGTreatment Duration Target48
16
8
123NRUTX1-1-BCSC-1016
REGIMESmoking RegimeTraditional combustible 
TRTDMAXTreatment Duration Max48.5
17
9
123NRUTX1-1-BCSC-10
RUN 
17

Assay run number

1

Identified at result level, 

TRTDUTreatment Duration UnitHOURS
18
10
123NRUTX1-1-BCSC-1018
PORT
INCBTMP
Port ID
Incubation Temperature
1
37
11
19123NRUTX1-1-BCSC-1019
SMPLIDSample ID030001
INCBTMPUIncubation Temperature UnitC
20
12
123NRUTX1-1-BCSC-10
SMKFRC
20
Smoke FractionASMKEXSYSSmoke Exposure SystemCambridge filter pad, eluted in DMSO
MEDIAComposition of MediaSartorius HEK293
21
13
123NRUTX1-1-BCSC-1021
REPNUM Replicate Number1
HUMIDAtmospheric Relative Humidity  Percent90
22
14
123NRUTX1-1-BCSC-1022
ITVCONCintervention concentration10
ATMCO2Atmospheric CO2 Percent5
23
15
123NRUTX1-1-BCSC-1023
ITVCONCUintervention unit
SPTOBID

Sponsor defined tobacco identifier

CIG01a
ug/ml
...


...





123NRUTX1-10-HSLS-10
PLATENUMPlate number1  

123NRUTX1-10-HSLS-10
WELLNUMNumber representing the location of the well in the 96-well plate10-H

123NRUTX1-10-HSLS-10
INTRVNname of the intervention articlesodium laurel sulfate

123NRUTX1-10-HSLS-10
ITVTYPEtype of intervention articlePOSITIVE CONTROL

123NRUTX1-10-HSLS-10
ITVCONCintervention concentration200

123NRUTX1-10-HSLS-10
ITVCONCUintervention unitug/ml
...


...





123NRUTX2-10-HSLS-10
PLATENUMPlate number2

123NRUTX2-10-HSLS-10
WELLNUMNumber representing the location of the well in the 96-well plate10-H

123NRUTX2-10-HSLS-10
INTRVNname of the intervention articlesodium laurel sulfate

123NRUTX2-10-HSLS-10
ITVTYPEtype of intervention articlePOSITIVE CONTROL

123NRUTX2-10-HSLS-10
ITVCONCintervention concentration200

123NRUTX2-10-HSLS-10
ITVCONCUintervention unitug/ml
...


...




Expand
titlegt.xpt (similar to LB)

RowSTUDYIDASSAYIDDOMAINTXSETCDGTSEQGTTESTCDGTTESTGTORRESGTORRESUGTSTRESCGTSTRESNGTSTRESU
1123NRUGT1-1-A1RELABSRelative Absorbance Reading100ug/ml100100ug/ml
2123NRUGT1-1-B1RELABSRelative Absorbance Reading107ug/ml100100ug/ml
3123NRUGT1-1-C1RELABSRelative Absorbance Reading98.6ug/ml100100ug/ml
4123NRUGT1-1-D1RELABSRelative Absorbance Reading94.9ug/ml100100ug/ml
5123NRUGT1-1-E1RELABSRelative Absorbance Reading111ug/ml111111ug/ml

123NRUGT1-1-F1RELABSRelative Absorbance Reading96.9ug/ml96.996.9ug/ml

123NRUGT1-1-G1RELABSRelative Absorbance Reading105ug/ml105105ug/ml

123NRUGT1-1-H1RELABSRelative Absorbance Reading95.2ug/ml95.295.2ug/ml
10123NRUGT1-2-A1RELABSRelative Absorbance Reading

83.0

ug/ml83.083.0ug/ml
11123NRUGT1-2-B1RELABSRelative Absorbance Reading77.7

ug/ml

77.777.7ug/ml
...


...







80123NRUGT1-10-H1RELABSRelative Absorbance Reading0.791ug/ml0.7910.791ug/ml
...


...







160123NRUGT2-10-H1RELABSRelative Absorbance Reading0.780ug/ml0.7800.780ug/ml